Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
Sponsor: University of British Columbia
Collaborator: EntheoTech Bioscience Inc.
Recruitment Status: Not yet recruiting
First Posted: Oct 18, 2022
~
Sponsor: Sunstone Medical
Recruitment Status: Recruiting
First Posted: Oct 18, 2022
~
(Chapter) Drug and MDMA Interactions Implications for Public Health (Papaseit et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 2243–2268
~
(Chapter) The Toll of Benzofurans in the Context of Drug Abuse (Bravo et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 3065–3088
~
(Chapter) Psilocybin and Magic Mushrooms: Patterns of Abuse and Consequences of Recreational Misuse (Brito-da-Costa et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 2427–2455
~
(Chapter) Pathological Effects and Adverse Events Associated with the Phenylethylamine Derivative NBOMe (Wadowski et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 3015–3029
~
(Chapter) Pharmacological Action of LSD (Herian et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 2457–2475
~
(Chapter) 3,4-Methylenedioxymethamphetamine (MDMA) and Synaptic Dopamine (Rizzo et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 2195–2213
~
(Chapter) Life-Threatening 3,4‐Methylenedioxyamphetamine (MDMA) Usage (Chu)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 2337–2364
~
(Chapter) The Biology of Nitric Oxide Signaling and MDMA (García-Pardo et al.)
Published: Oct 18, 2022
Handbook of Substance Misuse and Addictions pp 2337–2364
~
Canonical and Non-Canonical Psychedelic Drugs Induce Common Network Changes in Human Cortex (Dai et al.)
Published: Oct 18, 2022
bioRxiv
~
Does Mystical Experience Give Access to Reality? (Marshall)
Published: Oct 18, 2022
Religions
